Frailty and the selection of patients for destination therapy left ventricular assist device - Wikidata - wikimedia - TriplyDB

Frailty and the selection of patients for destination therapy left ventricular assist device

Frailty and the selection of patients for destination therapy left ventricular assist device

http://www.wikidata.org/entity/Q37407820

about

Improved Cardiovascular Disease Outcomes in Older Adults Decision making for destination therapy left ventricular assist devices: "there was no choice" versus "I thought about it an awful lot"Frailty assessment in the cardiovascular care of older adults Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillation Reversibility of Frailty After Bridge-to-Transplant Ventricular Assist Device Implantation or Heart Transplantation Role of frailty assessment in patients undergoing cardiac interventions Reduced handgrip strength as a marker of frailty predicts clinical outcomes in patients with heart failure undergoing ventricular assist device placement Regulation of Cardiac Autonomic Nervous System Control across Frailty Statuses: A Systematic Review Association of global and disease-specific health status with outcomes following continuous-flow left ventricular assist device implantation.Patients' decision making process and expectations of a left ventricular assist device pre and post implantation.Defining the threshold for too sick for transplant.Slow Gait Speed and Risk of Mortality or Hospital Readmission After Myocardial Infarction in the Translational Research Investigating Underlying Disparities in Recovery from Acute Myocardial Infarction: Patients' Health Status Registry.A review of ethical considerations for ventricular assist device placement in older adults High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry Pre-operative health status and outcomes after continuous-flow left ventricular assist device implantation.Frailty and outcomes after implantation of left ventricular assist device as destination therapy Rotary blood pumps as definitive treatment for severe heart failure.INTERMACS and MedaMACS: how will they guide future therapy?Frailty in cardiothoracic surgery: systematic review of the literature.Prognostic and Therapeutic Implications of Frailty in Older Adults with Heart Failure.The prevalence of frailty in heart failure: A systematic review and meta-analysis.Frequency of and Significance of Physical Frailty in Patients With Heart Failure.Pathophysiology of heart failure and frailty: a common inflammatory origin?Targeting Frailty in Heart Failure.Heart Failure in Older Adults.Global Outcome in Patients With Left Ventricular Assist Devices.Transplant for the very sick: No limitations in donor quality?Association between preoperative peripheral blood mononuclear cell gene expression profiles, early postoperative organ function recovery potential and long-term survival in advanced heart failure patients undergoing mechanical circulatory support.The prognostic significance of frailty compared to peak oxygen consumption and B-type natriuretic peptide in patients with advanced heart failure.Reviewing the use of ventricular assist devices in the elderly: where do we stand today?Can a Left Ventricular Assist Device in Individuals with Advanced Systolic Heart Failure Improve or Reverse Frailty?Identifying a Relationship Between Physical Frailty and Heart Failure Symptoms.Current indications for transplantation: stratification of severe heart failure and shared decision-making.Comparison of continuous-flow ventricular assist device therapy with intensive medical therapy in fixed pulmonary hypertension secondary to advanced left heart failure.

P2860

Q26766094-3A8AED94-81F1-4A2D-A896-BCCE80FFC520 Q28240001-9C9B15E1-BC29-4E8E-8E4E-6111216B6441 Q28303050-235E8B83-BD96-484E-8611-0FE76DC1BE84 Q33680031-885451E2-15D1-489D-B344-3BED7F0B1600 Q33873974-18334CDA-701D-46E0-BA93-780BA92A4A6B Q34333218-CB2C6133-8885-4CC4-9821-8C32D77B8656 Q34824162-1B489D6F-F326-4F2A-BDB2-4A51583E50C9 Q35687317-98C95E5B-1237-4F71-A303-14F3B21D86A7 Q36306558-69032104-EC84-42E0-A5F6-3286E73A8AB9 Q36654892-4C3D11E3-D9F0-42A9-989E-357DCC94AB7E Q36673804-424C8DC7-6C78-41A4-AC62-81ECCC76D42B Q36716925-73FC1208-F607-4E82-9B84-EAF94C6FC7BC Q36859904-BEA0BA4E-1759-4FEA-82EA-20CE0DB40558 Q37029809-03162F71-F979-4B00-BE2D-CE08EE1A5FFE Q37337303-DAEFDC86-6055-4534-BC7B-AE740AAD9A92 Q37666008-F7A16A44-2769-499A-AE71-62784358FBBD Q38086842-F1616F42-336E-4991-9AFD-0F7453C79027 Q38123741-452348EB-AEC9-4B1E-969E-B0B6A6BF5325 Q38444374-F3EDD1C0-6F3B-472A-AB84-CFF2DBB77E7E Q38582389-222A7200-1590-47D8-A537-5907664CFB22 Q38755652-C156EB26-71FA-4622-B2B8-BEF49A22DBBE Q39139565-96031079-C677-4374-9975-53CEEBB27949 Q39165266-368AB59C-8C97-4FEC-9FAC-2E127303C22D Q39208375-F975324E-7498-4A01-BF5C-4492DF915888 Q39540471-E6F6F73C-392D-45C1-8772-4EE66098B02B Q40349834-A8C0EC9D-9EEA-41FA-985F-BB69911B7C20 Q43726265-E2B2C7D6-1498-41DC-A06C-2E37CA5D4109 Q46129739-14FE4F01-772F-4275-A17E-4B31197FBB9C Q47321634-56EF7FF6-8BF9-4812-806F-8F28956B4AB5 Q47577914-E1584D9B-D96F-4B50-9184-A0682D4381FB Q47644166-5E3FE154-DA74-4CC2-BA18-9817EAD18530 Q47931299-117FEF3B-1EF2-4E00-ADCD-D6919CEAB9BD Q50332202-5DA992B1-E9AA-4EB9-ABBB-1D57D9B2E8A1 Q52638634-784AF0AF-08FB-45E6-A1B6-4695412301D9

P2860

Frailty and the selection of patients for destination therapy left ventricular assist device

http://www.wikidata.org/entity/Q37407820

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Frailty and the selection of p ...... left ventricular assist device

@en

Frailty and the selection of p ...... eft ventricular assist device.

@nl

type

label

Frailty and the selection of p ...... left ventricular assist device

@en

Frailty and the selection of p ...... eft ventricular assist device.

@nl

prefLabel

Frailty and the selection of p ...... left ventricular assist device

@en

Frailty and the selection of p ...... eft ventricular assist device.

@nl

P1433

Q37407820-A958E634-869A-442D-82B0-AC72538390DA

P1476

Q37407820-888992A9-B973-4AB6-B1ED-1595524606B0

P2093

Q37407820-2B8F0B98-36B1-4F39-80D4-5AC34A072C27

Q37407820-91B7E9DF-E890-4566-A97C-98316321D39F

Q37407820-CCC5AC36-0677-40C7-B519-ADC6799F48D4

Q37407820-D254EF51-84B0-4473-A231-D2E2686DCA62

P2860

Q37407820-03D92875-115F-4C12-BD02-F2CC16FEB9A4

Q37407820-074D8550-D41D-47CF-927E-A11DBE0BD1F2

Q37407820-1D8284CE-6ED9-4513-8A9B-5FEE3803223F

Q37407820-35904D44-F344-4677-80AE-E1336391716F

Q37407820-3A54C195-4642-4EB6-B41D-FBA041B3B9B5

Q37407820-3ECC90DA-3D1A-42D1-9C00-D18A791C5718

Q37407820-4BECCFB2-F4C8-4289-9303-7DB229EF90AF

Q37407820-4D696E62-0E2B-455C-BAC5-5840007128A0

Q37407820-4E6D29F9-28BB-49C2-A411-467970AD8D4A

Q37407820-4F75340D-12A6-484F-A60F-0CB218DF72E6

P304

Q37407820-743F4850-797C-4473-823B-146E0062C2A3

P31

Q37407820-2AFAE4B3-6481-42B0-828F-83888BF80B2E

P356

Q37407820-DA5B56B9-B5F8-4F93-B2CA-0CD54CCD8245

P433

Q37407820-52B384EB-97B1-45ED-B18F-F2CC2ACA22EF

P478

Q37407820-3C1BE2EB-6D5C-4DC7-AE9F-9F422206C983

P577

Q37407820-55F3EAC6-AE34-4578-8FFE-4779D760E1FD

P5875

Q37407820-FCADE772-68F3-4D44-AF8E-68DAF2B4BB2A

P698

Q37407820-164FEFA0-62CF-43A0-BE31-3A786C3CBA89

P932

Q37407820-2B1340D0-6AD5-4C32-A554-731829FFF1C9

P356

CIRCHEARTFAILURE.111.963215

P1433

Circulation: Heart Failure

P1476

Frailty and the selection of p ...... left ventricular assist device

@en

P2093

Daniel D Matlock

http://www.w3.org/2001/XMLSchema#string

Joann Lindenfeld

http://www.w3.org/2001/XMLSchema#string

Kelsey M Flint

http://www.w3.org/2001/XMLSchema#string

Larry A Allen

http://www.w3.org/2001/XMLSchema#string

P2860

Frailty in older adults: evidence for a phenotype

Use of a continuous-flow device in patients awaiting heart transplantation

Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care

Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device

Clinical management of continuous-flow left ventricular assist devices in advanced heart failure

Frailty as a predictor of surgical outcomes in older patients

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Social vulnerability, frailty and mortality in elderly people.

Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality.

Midlife hand grip strength as a predictor of old age disability.

P304

286-293

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCHEARTFAILURE.111.963215

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221967417

http://www.w3.org/2001/XMLSchema#string

P698

22438521

http://www.w3.org/2001/XMLSchema#string

P932

3869992

http://www.w3.org/2001/XMLSchema#string